Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Dermatology/Plastic Surgery | Rheumatology
Disease Category: Psoriasis and Psoriatic Disorders

Trial Information

Psoriasis Study CAIN457A2211

The purpose of this study is to determine dosages, measure effectiveness of reducing plaque psoriasis symptoms and verify the safety of the subcutaneously administered (injections under the skin) study drug, in participants who were diagnosed at least 6 months ago with moderate to severe chronic plaque psoriasis.

This study drug is an investigational drug, which means it is being tested and is not approved for sale in the United States by the U.S. Food and Drug Administration (FDA).


www.NovartisClinicalTrials.com

Research Center
Located In:
Various Cities, AR

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.